Implied Podcast

Qfin Holdings has absolutely cratered, dropping over 70% from its highs after a brutal cocktail of Chinese regulatory crackdowns, an industry-wide liquidity crunch, and a massive 19% single-day crash. With revenues sinking 32% and class-action lawsuits piling up, the market is pricing in a total disaster. But is the fear overblown? In this episode of Implied, we break down why Qfin is now trading at a ridiculously low 1.3 P/E ratio—and why the average Wall Street price target still implies a wild 115% upside. Tune in to find out if this beaten-down fintech is a dangerous falling knife or a massive opportunity for the brave money willing to hold through the pain.

Dell’s stock is in a massive tailspin, tumbling over 9% today on top of yesterday’s 11% plunge after a sharp Barclays downgrade to Equal Weight chilled the AI hardware trade. With insider sales hitting a staggering $3.5 billion over the last 12 months and a trailing P/E soaring past 29x, was this selloff an inevitable reality check—or an overreaction for a global infrastructure powerhouse? In this episode of Implied, we break down what triggered the panic, examine Dell's core ISG fundamentals, and evaluate whether institutional buyers might step in for a short-term bounce.

DigitalOcean just fell off a cliff, plunging 14% and wiping out a tenth of its market value in a single trading session. The crazy part? The company’s fundamentals look solid, boasting strong full-year 2026 earnings guidance and a recent $725 million move to expand its AI cloud capacity. So why the sudden panic? In this episode of Implied, we break down how broader macro tech fears, squeezed cloud multiples, and routine insider selling triggered this aggressive selloff. Is this a real warning sign for the developer platform, or just a massive tech sector rotation creating a rare dip-buying opportunity? Tune in to find out if DOCN is setting up for a rapid snapback.

Summit Therapeutics just got hit with an 8.6% drop, slipping to $15.65 despite massive underlying momentum. Why are investors slamming the sell button on one of biotech’s hottest names right after AstraZeneca backed them with a $2 billion investment? In this episode of Implied, we break down what’s really behind the pull-back—from pre-earnings profit-taking to technical moving average breakdowns. Is this $13B cancer drug innovator facing real friction, or is this steep dip the perfect entry point before Q3 earnings? Tune in for the full story.

Ciena just suffered a violent 10% reversal, crashing back to earth after last week's massive AI-networking rally. Despite having the game-changing tech needed to build the future of hyperscale data centers, a nosebleed valuation and physical supply chain bottlenecks are bringing investors back to reality. Throw in some sudden insider selling, and Wall Street is taking profits. In this episode of Implied, we break down the physical limits of the AI hardware boom, why infrastructure takes time to scale, and whether this sudden pullback is a warning sign... or the exact entry point big money has been waiting for.

AST SpaceMobile just took a massive hit, dropping 11.6% after Elon Musk’s SpaceX reportedly snatched up the highly coveted 800 MHz spectrum block it desperately needed. With a painful $230 million net loss, recent share dilution, and heavy insider selling, Wall Street is hitting the panic button on the direct-to-cell startup. But with a $2.7 billion war chest, 13 satellites already in orbit, and a $1.3 billion revenue backlog, AST isn't running on fumes just yet. In this episode of Implied, we break down what this fierce rivalry means for the telecom world and whether this massive selloff is a red flag… or a rare buy-the-dip opportunity for long-term value hunters.

Planet Fitness has taken a heavy beating over the last year, plummeting over 50% from its 52-week high of $114 down to the low-$50s. But beneath the Wall Street noise, the underlying data reveals a classic value setup. Despite macro headwinds, the gym giant just beat Q2 earnings, proved strong pricing power after raising member fees by 50%, and sparked a massive insider buying spree from the CEO and board members. In this episode of Implied, we break down whether Wall Street has severely mispriced $PLNT's resilient franchise model—or if tightening consumer budgets pose a real threat. Tune in to see if this steep selloff signals danger or a rare chance to buy high-margin growth on sale.

Novo Nordisk shares just plummeted 8% after management’s Capital Markets Day left Wall Street underwhelmed by its growth targets through 2030. Despite trading at a bargain P/E of 9.7 with a solid 4% dividend yield, investors panicked over the upcoming 2032 Wegovy and Ozempic patent cliff, slowing prescription growth, and mounting competition from Eli Lilly. In this episode of Implied, we break down whether this steep selloff is an emotional Wall Street overreaction that creates a classic value entry point—or a warning that the pharma giant’s explosive growth era is coming to an end. Tune in for the full story behind the drop!

Enova International just suffered a brutal 22% single-day crash after scrapping its $369 million acquisition of Grasshopper Bancorp—killing its shortcut to a coveted bank charter. But while traders panicked, Enova’s core lending business is thriving, with management reaffirming 30% earnings growth and backed by $349 million in buybacks. In this episode of Implied, we break down why regulators stalled the deal, why top analysts are keeping their Buy ratings, and whether this steep selloff is a Wall Street temper tantrum that created a rare bargain.

Walmart stock just suffered a brutal 9% nose-dive, even after beating earnings estimates with an adjusted EPS of $0.81. The culprit? U.S. same-store sales growth hit a 6-year low at just 2.6%, sparking fears that budget-conscious shoppers are finally pulling back. In this episode of Implied, we break down why a defensive powerhouse with $187.9B in quarterly revenue got hammered by Wall Street, how intense rivalry from Target and Amazon is squeezing margins, and whether Walmart's aggressive price cuts on 11,000+ items make this crash a rare buying opportunity—or a warning sign for the broader economy. Tune in to uncover the story behind today's massive market reaction!